![Dave Gardner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dave Gardner
Corporate Officer/Principal bei
INCYTE CORPORATION
Vermögen: 912 161 $ am 31.05.2026
Profil
Dave Gardner is Chief Strategy Officer & Executive Vice President at Incyte Corp.
since 2025.
Former roles include Director at Xilio Therapeutics, Inc., Vice President at BlackRock Finance, Inc. from 2006 to 2015, and Analyst at Rock Springs Capital Management LP from 2015 to 2025.
Education includes an MBA from Columbia Business School conferred in 2015 and an undergraduate degree from McIntire School of Commerce.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.09.2025 | 9’429 ( 0% ) | 912 161 $ | 31.05.2026 |
Aktive Positionen von Dave Gardner
| Unternehmen | Position | Beginn |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 22.09.2025 |
Ehemalige bekannte Positionen von Dave Gardner
| Unternehmen | Position | Ende |
|---|---|---|
Rock Springs Capital Management LP
 Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Analyst-Equity | 01.09.2025 |
BlackRock Finance, Inc.
 BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Corporate Officer/Principal | 01.05.2015 |
| XILIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Dave Gardner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Finance |
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McIntire School of Commerce
 McIntire School of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
